Drug price controls have populist appeal, but patients are the ones they would hurt the most bit.ly/1X3e742 http://t.co/ulXuGHLSld—
Manhattan Institute (@ManhattanInst) October 17, 2015
@BernieSanders @HillaryClinton drug price controls will shorten lives
21 Oct 2015 Leave a comment
in applied price theory, applied welfare economics, economics of regulation, entrepreneurship, health economics, politics - USA Tags: 2016 presidential election, creative destruction, drug lags, entrepreneurial alertness, innovations, intellectual property, patents and copyright, price controls
Drug Price Controls End Up Costing Patients Their Lives
24 Sep 2015 Leave a comment
in applied price theory, applied welfare economics, comparative institutional analysis, economics of regulation, entrepreneurship, health economics, industrial organisation, law and economics, politics - USA, property rights, survivor principle Tags: creative destruction, endogenous growth theory, innovation, intellectual property rights, patents and copyrights, pharmaceutical innovation, price controls
Our research shows that when prices fall, innovation falls even more. Patients would see their lives cut short by delayed or absent drugs.
Source: Drug Price Controls End Up Costing Patients Their Health – NYTimes.com
…cutting prices by 40 to 50 percent in the United States will lead to between 30 and 60 percent fewer R and D projects being undertaken in the early stage of developing a new drug. Relatively modest price changes, such as 5 or 10 percent, are estimated to have relatively little impact on the incentives for product development – perhaps a negative 5 percent.
Source: The Effect of Price Controls on Pharmaceutical Research
Utopia, you are standing in it! 
Recent Comments